Ovoester

Related Terms

3,3'-Dihydroxy-4,4'-diketo-beta-carotene, 3,3'-dihydroxy-beta,beta'-caroten-4,4'-dione, 3R,3'R-astaxanthin, 3R,3'S-astaxanthin, 3S,3'S-astaxanthin, Agrobacterium aurantiacum, alpha-carotene, Antarctic krill, AST, AstaCarox?, AstaFactor? Rejuvenating Formula, AstaFactor? Sports Formula, Astavita AstaREAL?, astaxanthin diester, astaxanthin dilysinate tetrahydrochloride, astaxanthin-amino acid conjugate, astaxanthine, Astaxin?, ASX, Atlantic salmon, basidiomycete yeast, beta-carotene, Botryococcus braunii, canthaxanthin, canthoxanthin, Cardax?, carotenoid, CDX-085, Chlorella zofingiensis, Chlorococcum spp., crayfish, crustaceans, DDA, disodium disuccinate astaxanthin, E161j, Euphausia superba, fatty acids, flamingo, gamma-tocopherol, green microalgae, Haematococcus algae extract, Haematococcus pluvialis, homochiral (3S,3'S)-astaxanthin, krill, lutein, lycopene, meso-3R,3'S isomer, meso-astaxanthin, microalgae, nonesterified astaxanthin, non-provitamin A carotenoid, omega-3 fatty acids, ovoester, Phaffia rhodozyma, propolis, quail, red carotenoid, retinoid, salmon, shrimp, sockeye salmon, storks, terpenoids, tetrahydrochloride dilysine astaxanthin salt, tomato, trout, wild salmon, Xanthophyllomyces dendrorhous, xanthophylls.

Background

Astaxanthin is a naturally occurring carotenoid found in nature primarily in marine organisms such as microalgae, salmon, trout, krill, shrimp, crayfish, and crustaceans. The green microalga Haematococcus pluvialis is considered the richest source of astaxanthin. Other microalgae, such as Chlorella zofingiensis, Chlorococcum spp., and Botryococcus braunii, also contain astaxanthin. It may also be found in the feathers of birds, such as quail, flamingo, and storks, as well as in propolis, the resinous substance collected by bees.
Carotenoids are well known for their therapeutic benefits in the aging process and various diseases, because of their antioxidant properties. Astaxanthin is a xanthophyll carotenoid like lutein, zeaxanthin, and cryptoxanthin, which do not convert to vitamin A.
According to a review, carotenoids are of interest based on their beneficial mechanisms of action for cancers, cardiovascular disease, age-related macular degeneration, and cataract formation. Numerous studies support the use of astaxanthin as a potent antioxidant that may be beneficial in decreasing the risks of certain chronic diseases. It may also reduce oxidative stress in the nervous system, reducing the risk of neurodegenerative diseases. Additionally, astaxanthin has well-documented anti-inflammatory and immune-stimulating effects.
Human trials have been conducted in disorders such as carpal tunnel syndrome, rheumatoid arthritis, dyspepsia (with or without Helicobacter pylori infection), hyperlipidemia, male infertility, and skin conditions, and regarding exercise capacity, muscle soreness, and transplants. However, results have been mixed, and more research is needed in these areas before any firm conclusions can be drawn.

Evidence Table

These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. GRADE *
These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. GRADE *


Evidence suggests that astaxanthin may have antioxidant activity. Additional research is needed to confirm these results.

B


Evidence suggests that astaxanthin may have antioxidant activity. Additional research is needed to confirm these results.

B


Preliminary research suggests that astaxanthin, as part of a multi-ingredient antioxidant supplement, may reduce pain and duration associated with carpal tunnel syndrome. However, larger studies are warranted before a conclusion can be drawn.

C


Preliminary research suggests that astaxanthin, as part of a multi-ingredient antioxidant supplement, may reduce pain and duration associated with carpal tunnel syndrome. However, larger studies are warranted before a conclusion can be drawn.

C


Limited evidence suggests that astaxanthin may be beneficial in dyspepsia. Additional evidence is warranted before a conclusion can be drawn.

C


Limited evidence suggests that astaxanthin may be beneficial in dyspepsia. Additional evidence is warranted before a conclusion can be drawn.

C


High-quality evidence supporting the use of astaxanthin to improve exercise capacity is lacking. More studies are warranted before a conclusion can be drawn.

C


High-quality evidence supporting the use of astaxanthin to improve exercise capacity is lacking. More studies are warranted before a conclusion can be drawn.

C


High-quality evidence supporting the use of astaxanthin for high cholesterol is lacking. More studies are warranted before a conclusion can be drawn.

C


High-quality evidence supporting the use of astaxanthin for high cholesterol is lacking. More studies are warranted before a conclusion can be drawn.

C


Preliminary research suggests that astaxanthin, as part of a multi-ingredient supplement, may benefit patients with macular degeneration. However, studies evaluating astaxanthin alone are warranted before a conclusion can be drawn.

C


Preliminary research suggests that astaxanthin, as part of a multi-ingredient supplement, may benefit patients with macular degeneration. However, studies evaluating astaxanthin alone are warranted before a conclusion can be drawn.

C


Limited evidence suggests that astaxanthin may be beneficial in male infertility. Additional evidence is warranted before a conclusion can be drawn.

C


Limited evidence suggests that astaxanthin may be beneficial in male infertility. Additional evidence is warranted before a conclusion can be drawn.

C


According to preliminary research, a combination product containing astaxanthin was found to reduce climacteric symptoms in women with menopause. Studies evaluating astaxanthin alone are needed before a conclusion can be drawn.

C


According to preliminary research, a combination product containing astaxanthin was found to reduce climacteric symptoms in women with menopause. Studies evaluating astaxanthin alone are needed before a conclusion can be drawn.

C


Evidence supporting the use of astaxanthin for muscle soreness is lacking. More studies are warranted before a conclusion can be drawn.

C


Evidence supporting the use of astaxanthin for muscle soreness is lacking. More studies are warranted before a conclusion can be drawn.

C


According to preliminary research, astaxanthin may be beneficial in alleviating pain and improving the ability to perform daily activity in patients with rheumatoid arthritis. However, larger studies are warranted before a conclusion can be drawn.

C


According to preliminary research, astaxanthin may be beneficial in alleviating pain and improving the ability to perform daily activity in patients with rheumatoid arthritis. However, larger studies are warranted before a conclusion can be drawn.

C


According to preliminary research, astaxanthin may help reduce fine lines and wrinkles and improve skin elasticity and moisture content. More studies are warranted before a conclusion can be drawn.

C


According to preliminary research, astaxanthin may help reduce fine lines and wrinkles and improve skin elasticity and moisture content. More studies are warranted before a conclusion can be drawn.

C


There is an ongoing study being conducted assessing the effects of astaxanthin on vascular structure, oxidative stress, and inflammation in renal transplant patients. Results of this trial are pending.

C


There is an ongoing study being conducted assessing the effects of astaxanthin on vascular structure, oxidative stress, and inflammation in renal transplant patients. Results of this trial are pending.

C
* Key to grades

A: Strong scientific evidence for this use
B: Good scientific evidence for this use
C: Unclear scientific evidence for this use
D: Fair scientific evidence for this use (it may not work)
F: Strong scientific evidence against this use (it likley does not work)
* Key to grades

A: Strong scientific evidence for this use
B: Good scientific evidence for this use
C: Unclear scientific evidence for this use
D: Fair scientific evidence for this use (it may not work)
F: Strong scientific evidence against this use (it likley does not work)

Tradition / Theory

The below uses are based on tradition, scientific theories, or limited research. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. There may be other proposed uses that are not listed below.

Dosing

Adults (18 years and older)
As an antioxidant, in general, manufacturers recommend taking 4-8 milligrams of astaxanthin by mouth 2-3 times daily with meals. Clinical evidence is lacking.
For dyspepsia, 40 milligrams of astaxanthin (AstaCarox?) has been taken by mouth daily in divided doses for four weeks.
For exercise capacity, the manufacturers of Xanthin? recommend taking one capsule by mouth (each containing eight milligrams of astaxanthin) before and after physical activity. Four milligrams of astaxanthin has also been taken by mouth in the morning with food.
For high cholesterol, 6, 12, and 18 milligrams of astaxanthin (AstaREAL? Astaxanthin) has been taken by mouth daily for 12 weeks. In healthy human subjects, 3.6, 7.2, and 14.4 milligrams has been administered in a beverage daily for two weeks.
For male infertility, 16 milligrams of astaxanthin (AstaCarox?) has been taken by mouth daily for three months.
For skin conditions, two milligrams of astaxanthin (Astavita AstaREAL? Astaxanthin; each capsule containing two milligrams of astaxanthin derived from Haematococcus plubialis microalgae) has been taken by mouth twice daily with breakfast and dinner for six weeks. According to secondary sources, four milligrams of astaxanthin (BioAstin?) daily for two weeks may prevent sunburn.
For transplant (renal), 12 milligrams of astaxanthin (BioAstin?; four milligram tablets taken by mouth three times daily) has been used for one year.
Note: Various seafoods contain the astaxanthin pigment. A standard serving portion of four ounces of Atlantic salmon contains from 0.5 to 1.1 milligrams of astaxanthin, whereas the same amount of sockeye salmon may contain 4.5 milligrams of astaxanthin.

Safety

The U.S. Food and Drug Administration does not strictly regulate herbs and supplements. There is no guarantee of strength, purity or safety of products, and effects may vary. You should always read product labels. If you have a medical condition, or are taking other drugs, herbs, or supplements, you should speak with a qualified healthcare provider before starting a new therapy. Consult a healthcare provider immediately if you experience side effects.

Interactions

Interactions with Drugs
Astaxanthin may increase the risk of bleeding or blood clotting when taken with drugs that increase such risks. Some examples include aspirin, anticoagulants (blood thinners) such as warfarin (Coumadin?) or heparin, antiplatelet drugs such as clopidogrel (Plavix?), and nonsteroidal anti-inflammatory drugs such as ibuprofen (Motrin?, Advil?) or naproxen (Naprosyn?, Aleve?).
Astaxanthin may lower blood sugar levels. Caution is advised when using medications that may also lower blood sugar. Patients taking insulin or drugs for diabetes by mouth should be monitored closely by a qualified healthcare professional, including a pharmacist. Medication adjustments may be necessary.
Astaxanthin may cause low blood pressure. Caution is advised in patients taking drugs, herbs, or supplements that lower blood pressure.
Astaxanthin may interfere with the way the body processes certain drugs using the liver's cytochrome P450 enzyme system. As a result, the levels of these drugs may be decreased in the blood and may reduce the intended effects. Patients taking any medications should check the package insert and speak with a qualified healthcare professional, including a pharmacist, about possible interactions.
Astaxanthin may interact with 5-alpha-reductase inhibitors, calcium salts, diabetes drugs, drugs that affect bleeding, heart medications, hormonal agents, immunosuppressants, and rofecoxib.

Attribution

This information is based on a systematic review of scientific literature edited and peer-reviewed by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com).

Bibliography

Andersen, L. P., Holck, S., Kupcinskas, L., Kiudelis, G., Jonaitis, L., Janciauskas, D., Permin, H., and Wadstrom, T. Gastric inflammatory markers and interleukins in patients with functional dyspepsia treated with astaxanthin. FEMS Immunol.Med Microbiol. 2007;50(2):244-248.
Belcaro, G., Cesarone, M. R., Cornelli, U., and Dugall, M. MF Afragil(R) in the treatment of 34 menopause symptoms: a pilot study. Panminerva Med 2010;52(2 Suppl 1):49-54.
Comhaire, F. H., El Garem, Y., Mahmoud, A., Eertmans, F., and Schoonjans, F. Combined conventional/antioxidant "Astaxanthin" treatment for male infertility: a double blind, randomized trial. Asian J Androl 2005;7(3):257-262.
Fassett, R. G. and Coombes, J. S. Astaxanthin: a potential therapeutic agent in cardiovascular disease. Mar.Drugs 2011;9(3):447-465.
Horie, S., Okuda, C., Yamashita, T., Watanabe, K., Kuramochi, K., Hosokawa, M., Takeuchi, T., Kakuda, M., Miyashita, K., Sugawara, F., Yoshida, H., and Mizushina, Y. Purified canola lutein selectively inhibits specific isoforms of mammalian DNA polymerases and reduces inflammatory response. Lipids 2010;45(8):713-721.
Kupcinskas, L., Lafolie, P., Lignell, A., Kiudelis, G., Jonaitis, L., Adamonis, K., Andersen, L. P., and Wadstrom, T. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study. Phytomedicine. 2008;15(6-7):391-399.
Lignell, ?. Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases. 1999;Patent Cooperation Treaty application #9911251
Liu, X. and Osawa, T. Astaxanthin protects neuronal cells against oxidative damage and is a potent candidate for brain food. Forum Nutr 2009;61:129-135.
Nakagawa, K., Kiko, T., Miyazawa, T., Carpentero, Burdeos G., Kimura, F., Satoh, A., and Miyazawa, T. Antioxidant effect of astaxanthin on phospholipid peroxidation in human erythrocytes. Br J Nutr 2011;105(11):1563-1571.
Parisi, V., Tedeschi, M., Gallinaro, G., Varano, M., Saviano, S., and Piermarocchi, S. Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year. Ophthalmology 2008;115(2):324-333.
Pashkow, F. J., Watumull, D. G., and Campbell, C. L. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol 5-22-2008;101(10A):58D-68D.
Serebruany, V., Malinin, A., Goodin, T., and Pashkow, F. The in vitro effects of Xancor, a synthetic astaxanthine derivative, on hemostatic biomarkers in aspirin-naive and aspirin-treated subjects with multiple risk factors for vascular disease. Am J Ther 2010;17(2):125-132.
Yamashita E. The effect of a dietary supplement containing astaxanthin on skin condition. Carotenoid Sci. 2006;10:91-95.
Yoshida, H., Yanai, H., Ito, K., Tomono, Y., Koikeda, T., Tsukahara, H., and Tada, N. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis 2010;209(2):520-523.
Yuan, J. P., Peng, J., Yin, K., and Wang, J. H. Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae. Mol Nutr Food Res 2011;55(1):150-165.